Figure 2: Swimmer Plot of Eligible Patient Population (N=21 evaluable, blue) and Ineligible Patient Population (N=11 evaluable, gray).

Figure 2: Swimmer Plot of Eligible Patient Population (N=21 evaluable, blue) and Ineligible Patient Population (N=11 evaluable, gray).

Tumor histologies are also shown. Eligible or ineligible designates whether a patient would qualify for the phase 3 clinical trial.

Format

JPEG

Source

Corvus Pharmaceuticals, Inc.

Downloads